Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shane Nho

Sports Medicine Chicago, IL Medical Doctor

NPI 1669649158 CMS profile 166011

1611 W Harrison St, Ste 400, Chicago, IL 60612

Open in the dashboard

General payments

$520,742

307 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$146,954 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Shane Nho of Chicago, IL is reported in the CMS Open Payments database as having received $520,742 across 307 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $146,954 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $91,684 44
2024 General $106,111 58
2023 General $90,689 38
2022 General $50,682 32
2021 General $78,866 54
2020 General $55,578 25
2019 General $47,132 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shane Nho
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Shane Nho were reported at $91,684. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Shane Nho Sports Medicine median Middle half National median
2019 $47,132 $1,176 $199–$4,249 $163
2020 $55,578 $708 $96–$2,890 $114
2021 $78,866 $1,213 $152–$3,994 $132
2022 $50,682 $1,230 $159–$3,998 $149
2023 $90,689 $584 $146–$2,836 $160
2024 $106,111 $628 $163–$3,168 $164
2025 $91,684 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $518,836 290 payments
  2. SI-BONE, Inc. $1,111 4 payments
  3. Ossur Americas., Inc $225 2 payments
  4. Smith+Nephew, Inc. $164 3 payments
  5. Linvatec Corporation $94 1 payment
  6. Zimmer Biomet Holdings, Inc. $92 1 payment
  7. Medical Device Business Services, Inc. $74 1 payment
  8. Vericel Corporation $70 3 payments
  9. Esaote North America, Inc. $58 1 payment
  10. Sanofi-Aventis U.S. LLC $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $250,743 86 payments
  2. Royalty or License $242,744 28 payments
  3. Travel and Lodging $14,727 50 payments
  4. Food and Beverage $12,308 142 payments
  5. Education $219 1 payment
Products named General payments · program years 2019–2025
  1. NA Arthroscopy $67,738 35 payments
  2. HIPMAP $54,817 22 payments
  3. HIPCHECK $35,264 13 payments
  4. NEW PRODUCT DEVELOPMENT $24,596 3 payments
  5. HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET $20,542 30 payments
  6. NANOTACK FLEX $15,496 18 payments
  7. TRIDENT $14,338 6 payments
  8. INSIGNIA $13,712 10 payments
  9. NA Sports Medicine $12,283 7 payments
  10. SPY-PHI SYSTEM $11,237 8 payments
  11. Other $70,950 145 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

119

Median for Sports Medicine: 144

Drug cost

$583

Median for Sports Medicine: $1,027

Branded share of claims

0%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 22 $225
Methylprednisolone Generic 36 $196
Meloxicam Generic 61 $162

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$71,882

Of which drugs: $1,674

Medicare patients

213

Average age 69

Services billed

3,589

148 women, 65 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 73%
High blood pressure 52%
Depression 23%
Osteoporosis 23%
Ischemic heart disease 18%
Diabetes 17%
Chronic kidney disease 11%
COPD 11%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 49 2,840 $281
Injection, methylprednisolone acetate, 40 mg J1030 Office 14 14 $66

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

307 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record